Given IRF4’s central role in MM tumorigenesis35 and the absence of POU motifs in the MM ATAC-seq data, we postulated that POU2AF1 might act as a novel transcriptional coactivator for IRF4 in MM cells. The gene discussed is POU2AF1; the disease is Miyoshi myopathy.